menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Robots could transform breast surgery forever

50 0
10.11.2026

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Robots could transform breast surgery forever

The technology is ready, but doctors are split.

“Wait, I can feel that?” Ami Brasure remembers thinking.

For most of us, the experience that dazzled her couldn’t be more ordinary: You’re standing around, maybe in your kitchen or living room, drinking something a little too carelessly, and before you know it, the liquid is dribbling down your chin and trickling down your chest — and you can feel it. It’s a familiar sensation (in this case, perhaps an embarrassing one). But for Brasure, a 50-year-old retail sales manager from the Washington, DC, area, it was life-affirming.

At the time, she was recovering from a double mastectomy in the wake of a stage one breast cancer diagnosis. She vividly remembers the chill from her spilled drink as it snaked its way inside the compression garment she was wearing as part of her recovery process. The sudden dampness came as a shock — not because it was unpleasant, but because she never expected to feel anything in that area at all, certainly not so soon after surgery.

Every year, hundreds of thousands of women in the United States are diagnosed with breast cancer and undergo mastectomies that can leave them with little to no feeling in their chests.

In December 2025, the FDA cleared the da Vinci single-port surgical system for robot-assisted breast cancer surgery, specifically nipple-sparing mastectomies.

Some surgeons are embracing this new technology because it offers a smaller, hidden scar and a clearer view inside the breast. Some patients also report better sensation in the chest area afterward.

But critics say that there isn’t conclusive long-term evidence yet that robotic nipple-sparing mastectomies are as good as open mastectomies at making sure the cancer doesn’t come back, even if they are technically safe to perform.

As Brasure knew, many people who get mastectomies are left with little to no feeling in their chests. That loss of sensation can affect a patient’s psychological well-being, sometimes actively alienating them from their bodies as they adjust to life after treatment.

“Every patient will have their own surgical goals. And mine was to look and feel as close as I did to how I looked and felt before I went into that operating room,” Brasure told me.

So when Dr. Lucy De La Cruz, chief of breast surgery at MedStar Georgetown University Hospital, offered Brasure the chance to be the hospital’s first patient to undergo a surgery that deployed a new robotic nipple-sparing mastectomy technique, she was enthusiastic. Especially because it was a procedure that some surgeons and studies have suggested leads to better preservation of feeling.

Using a robot to aid a mastectomy is not entirely novel — surgeons around the world have been experimenting with this technique for the past decade.

But what is new is that De La Cruz’s novel surgical plan combined several procedures into one operation. Using the da Vinci single-port robotic surgical system, she removed the breast tissue while preserving the nipples and skin. In the same operation, her team checked the lymph nodes, reconstructed the breasts with implants, and reconnected the nerve to the nipples to help restore sensation. In most robotic nipple-sparing mastectomies, the surgical incision is made along the armpit or the side of the chest. But here, De La Cruz and her team did everything through a single, 4-centimeter incision on each breast, naturally hidden under its fold. The hidden surgical scar and shorter recovery period, along with the possibility of having sensation back in her breasts post-surgery, were alluring for Brasure.

Normally, surgeons performed nipple-sparing mastectomies through more conventional “open” techniques, typically through a long incision at the bottom of the breast. It is a technically challenging operation. Breast tissue extends all the way up to the collarbone, and surgeons have to reach it through a tight space with limited visibility, relying on their hands and eyes to look and feel their way around the breast. An assistant often uses large metal retractors to lift the skin around the incision to keep the area exposed and visible.

The procedure also carries a known risk of injury to the skin and nipple, sometimes severe enough that patients can lose the nipple and surrounding skin. These challenges led some surgeons to explore whether a robot-assisted surgery could help mitigate certain risks of open nipple-sparing mastectomies. But it was only in December 2025 that the Food and Drug Administration specifically cleared the use of the da Vinci single-port machine to perform mastectomies in the United States.

And at least for Brasure, it seems to have made all the difference, helping her feel better connected to her body after a procedure that might, under other circumstances, have left her with a radically altered sense of it.

In theory, robotic nipple-sparing mastectomies sound like an amazing example of where surgical technology can take us. The American Cancer Society estimates that, in 2026, about 321,910 new cases of invasive breast cancer will be diagnosed in women. Many women opt for mastectomies not just as an active cancer treatment but also preventatively to reduce their risk, especially when they have a BRCA mutation — which indicates a very high likelihood of developing breast cancer — or a family history of the disease. A surgery with the potential to preserve more sensation, leave fewer surgical scars, and allow patients to recover more quickly promises to be a boon to women’s health.

Instead, robotic nipple-sparing mastectomies have proved extraordinarily divisive among oncological surgeons. Some, including De La Cruz, have embraced them. Others worry that the technology has gotten ahead of the evidence, especially on one of the most important measures in cancer treatment: making sure that the cancer doesn’t come back.

The most hopeful cancer news in years

The case for robotic mastectomies

Maleeha Aziz, a 33-year-old deputy director at an abortion fund in the Dallas-Fort Worth area, grew up around breast........

© Vox